<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02126202</url>
  </required_header>
  <id_info>
    <org_study_id>80+</org_study_id>
    <nct_id>NCT02126202</nct_id>
  </id_info>
  <brief_title>Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes</brief_title>
  <acronym>80+</acronym>
  <official_title>Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes: The Octogenarians Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicenter, randomized clinical trial in elderly patients (over 80 years old) with
      unstable angina pectoris or Non-ST elevation myocardial infarction (NSTEMI).

      A total of 200 patients will be randomized to medical treatment (100 patients) or coronary
      angiography with revascularization if feasible (100 patients). Information regarding prior
      history, frailty, clinical presentation, in-hospital events, complications, angina, quality
      of life and mortality will be collected. Follow up time is 1 year.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with major adverse cardiac and cerebral events (the composite of death, myocardial infarction, urgent revascularisation, recurrent hospitalization due to cardiac reason and stroke).</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with major bleeding</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with major adverse cardiac or cerebral event</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with minor bleeding</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with composite of cardiac death or myocardial infarction</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline of participants level of quality of life measured with the SF-36 questionnaire at 12 months</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline of participants level of angina pectoris at 12 months</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants dead (all cause mortality)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Non-ST Elevation Myocardial Infarction (NSTEMI)</condition>
  <condition>Angina, Unstable</condition>
  <arm_group>
    <arm_group_label>Conservative therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Optimized medical therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Invasive therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coronary angiography and revascularization if feasible</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angiography and revascularization if feasible</intervention_name>
    <description>Coronary angiography and revascularization with PCI or CABG (coronary artery bypass grafting) if feasible</description>
    <arm_group_label>Invasive therapy</arm_group_label>
    <other_name>Percutaneous coronary intervention (PCI)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. &gt;80 years of age

          2. Acute coronary syndrome with ischemic symptoms (mainly chest pain) lasting over 10
             minutes during the last 72 hours.

             AND at least one of the following:

               1. ST-segment depression on ECG &gt; 1mm

               2. Elevated cardiac troponins

          3. Written informed consent before randomization

        Exclusion criteria:

          1. Percutaneous coronary intervention (PCI) within 30 days prior to randomization

          2. Suspected ongoing active internal bleeding

          3. ST segment elevation of &gt;1mm in two contiguous leads on ECG

          4. Enrollment in another study that has not completed the follow up phase.

          5. Known allergy to aspirin or clopidogrel

          6. Severe dementia

          7. Expected limited 1 year survival due to other disease(s)

          8. Unwillingness to participate in the trial or expected problems with compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>80 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per A Albertsson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Per A Albertsson, MD, PhD</last_name>
    <phone>+46313421000</phone>
    <email>per.albertsson@vgregion.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology, Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berglind Libungan, MD</last_name>
      <phone>+46313421000</phone>
      <email>berglind.libungan@vgregion.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2014</study_first_posted>
  <last_update_submitted>April 27, 2014</last_update_submitted>
  <last_update_submitted_qc>April 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Per Albertsson</investigator_full_name>
    <investigator_title>Head of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Elderly</keyword>
  <keyword>Octogenarians</keyword>
  <keyword>PCI</keyword>
  <keyword>Myocardial infarction</keyword>
  <keyword>NSTEMI</keyword>
  <keyword>Unstable angina pectoris</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

